Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus
- 1 July 2015
- journal article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 78, 137-141
Abstract
No abstract availableKeywords
Funding Information
- CSIR-YSA001
- CSIR-UNDO (BSC0103)
- CSIR-GENESIS (BSC0121)
This publication has 20 references indexed in Scilit:
- Inhibitors of the Glyoxylate Cycle Enzyme ICL1 in Candida albicans for Potential Use as Antifungal AgentsPLOS ONE, 2014
- Isocitrate Lyase: A Potential Target for Anti-Tubercular DrugsRecent Patents on Inflammation & Allergy Drug Discovery, 2013
- Advances in Mycobacterial Isocitrate Lyase Targeting and InhibitorsCurrent Medicinal Chemistry, 2012
- Screening of flavonoids for antitubercular activity and their structure–activity relationshipsMedicinal Chemistry Research, 2012
- Tuberculosis: What We Don’t Know Can, and Does, Hurt UsScience, 2010
- M. tuberculosis persistence, latency, and drug toleranceTuberculosis, 2004
- TB drug discovery: addressing issues of persistence and resistanceTuberculosis, 2004
- Transcriptional Adaptation of Mycobacterium tuberculosis within MacrophagesJournal of Experimental Medicine, 2003
- Mycobacterium tuberculosis: here today, and here tomorrowNature Reviews Molecular Cell Biology, 2001
- Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.Nature Structural & Molecular Biology, 2000